FeesSafety
Pluang+

CMTA approves Cardano smart-contract for Swiss tokenized-share certification process

Protocol Fundamentals
29 Oct 2026, 14:40 WIB
Tokenpost
View Source
Bullish
CMTA approves Cardano smart-contract for Swiss tokenized-share certification process

The Capital Markets and Technology Association (CMTA) has approved a reviewed Cardano smart-contract implementing CIP-0113 for use in its Swiss tokenized-share certification process. This approval allows the contract to replace CMTA’s reference contract once deployment conditions are met, but it only applies to tokenized shares and not to tokenized debt or base-layer infrastructure. The CIP-0113 standard, launched on Cardano mainnet on Oct. 7, enables issuers to attach compliance rules to native tokens, which are checked by the ledger during transactions. This development is significant as it supports legal and technical verification of tokenized shares under Swiss regulations, although each issuance still requires separate CMTA review and regulatory approvals.

The story about CMTA's recognition of a Cardano smart-contract for Swiss tokenized-share certification is presented with Pluang's market data for context. As of Oct 29, 2026 18:53 WIB, 7 out of 50 major cryptocurrencies traded on Pluang rose, while 42 fell. Among notable assets, MANA is priced at Rp1.393 with a 1-day change of -3.26%, DOT at Rp17.961 with -3.17%, and ONE at Rp23 with -2.94%.

More News

NCH performs US first tricuspid valve repair with PASCAL Precision system after FDA approval

NCH performs US first tricuspid valve repair with PASCAL Precision system after FDA approval

Naples Comprehensive Health (NCH) has completed the first tricuspid valve repair in the US using the PASCAL Precision system following FDA approval. This minimally invasive catheter-based procedure offers a new treatment option for patients with seve...

Market News
Bullish
1 hour ago
Immunocore to present Phase 1 data on brenetafusp and KIMMTRAK combo for metastatic uveal melanoma at SITC 2026

Immunocore to present Phase 1 data on brenetafusp and KIMMTRAK combo for metastatic uveal melanoma at SITC 2026

Immunocore Holdings will present Phase 1/2 clinical trial data for brenetafusp alone and combined with KIMMTRAK in treating metastatic uveal melanoma at the 2026 Society for Immunotherapy of Cancer meeting. This trial evaluates safety and efficacy in...

Company Fundamentals
Bullish
1 hour ago
Collegium Pharmaceutical and Boston Legacy FC expand partnership to support neurodivergent youth in Massachusetts sports.

Collegium Pharmaceutical and Boston Legacy FC expand partnership to support neurodivergent youth in Massachusetts sports.

Collegium Pharmaceutical and Boston Legacy FC have extended their partnership to include youth coach training, an annual Sports for All Summit, and sensory inclusion programs aimed at supporting neurodivergent children, especially those with ADHD, in...

Others
Bullish
2 hours ago
Gilat Satellite Networks to attend Deutsche Bank Global Space and Defense Tech Summit in NYC

Gilat Satellite Networks to attend Deutsche Bank Global Space and Defense Tech Summit in NYC

Gilat Satellite Networks announced that its CEO Adi Sfadia and CFO Gil Benyamini will attend the Deutsche Bank Global Space and Defense Tech Summit on November 18, 2026, in New York City. The event will feature one-on-one and group meetings, providin...

Market News
Neutral
2 hours ago
Boralex buys Wind2 to boost UK wind energy projects by 350 MW, expanding its renewable footprint.

Boralex buys Wind2 to boost UK wind energy projects by 350 MW, expanding its renewable footprint.

Boralex Inc. has acquired Wind2, a UK-based renewable energy developer with about 350 MW of advanced wind projects across Scotland, England, and Wales. This acquisition strengthens Boralex's presence and capabilities in the UK, aligning with its stra...

Company Fundamentals
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App